Consideration on core requirements for RMPs of COVID-19 vaccines

Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Sogroya, somapacitan, Date of authorisation: 31/03/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 12/12/2018, Revision: 7, Status: Withdrawn

Dynastat

Agenda - HMA/EMA Annual Data Forum 2025

Antiviral medicines for pandemic influenza

Signal management (veterinary medicines)

Veterinary good pharmacovigilance practices (VGVP)

Veterinary Union Pharmacovigilance Database - Best Practice Guide